Research & Development
We have built an unmatched drug discovery platform to identify and advance drug candidates against targets in the PI3K/Akt/mTOR signaling pathway and related pathways.
Pipeline
Our pipeline programs include both novel isoform-selective and pathway-selective inhibitors of members of the PI3K/Akt/mTOR signaling network.
Contact Us
Partnering with industry leaders is a key component of our growth strategy and is focused in two areas: pipeline opportunities and our PI3K/Akt/mTOR drug discovery platform.